P2RY2 and dry eye syndrome: Diquafosol, an agonist of the P2Y2 purinergic receptor, promotes mucin secretion and membrane-associated mucin expression on the ocular surface [23,24,25], thus maintaining the aqueous component of the tear film and improving dry eye symptoms and signs [26].